Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360)

Autor: Adriana Weinberg, Michelle A. Kendall, Alejo Erice, M. S. Hirsch, Bruce Polsky, Courtney N. Tierney, Angela M. Caliendo
Rok vydání: 2002
Předmět:
Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 37(4)
ISSN: 1537-6591
Popis: We undertook a prospective study to analyze cytomegalovirus (CMV) end-organ disease (EOD) in subjects with advanced human immunodeficiency virus (HIV) infection. Of 403 individuals without prior CMV EOD who were followed up for a median of 151 weeks, 56 died and 21 developed CMV EOD. Twenty of the subjects with CMV EOD had CD4 cell counts of ≤50 cells/mm 3 and HIV RNA level of >10,000 copies/mL of plasma at baseline; in these 20 subjects, an increase of CMV DNA level to greater than the quantification limits was associated with CMV EOD. A CD4 cell count of ≤100 cells/mm 3 and an HIV RNA level of >10,000 copies/ mL of plasma at baseline, a CMV DNA level of >200 copies/mL of blood during follow-up, or development of CMV EOD were all associated with decreased survival. HIV-infected subjects with CD4 cell counts of ≤50 cells/mm 3 and HIV RNA levels of >10,000 copies/mL of plasma should have blood fractions screened for CMV DNA; if CMV DNA is detected, CMV prophylaxis might be considered.
Databáze: OpenAIRE